questionsmedicales.fr
Composés chimiques organiques
Composés du soufre
Sulfones
Sulfonamides
Sulfonamides : Questions médicales fréquentes
Termes MeSH sélectionnés :
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Sulfonamides : Questions médicales les plus fréquentes",
"headline": "Sulfonamides : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Sulfonamides : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-01-25",
"dateModified": "2025-04-19",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Sulfonamides"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Sulfones",
"url": "https://questionsmedicales.fr/mesh/D013450",
"about": {
"@type": "MedicalCondition",
"name": "Sulfones",
"code": {
"@type": "MedicalCode",
"code": "D013450",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D02.886.590"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Bumétanide",
"alternateName": "Bumetanide",
"url": "https://questionsmedicales.fr/mesh/D002034",
"about": {
"@type": "MedicalCondition",
"name": "Bumétanide",
"code": {
"@type": "MedicalCode",
"code": "D002034",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D02.886.590.700.150"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Diclofénamide",
"alternateName": "Dichlorphenamide",
"url": "https://questionsmedicales.fr/mesh/D004005",
"about": {
"@type": "MedicalCondition",
"name": "Diclofénamide",
"code": {
"@type": "MedicalCode",
"code": "D004005",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D02.886.590.700.410"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Mafénide",
"alternateName": "Mafenide",
"url": "https://questionsmedicales.fr/mesh/D008272",
"about": {
"@type": "MedicalCondition",
"name": "Mafénide",
"code": {
"@type": "MedicalCode",
"code": "D008272",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D02.886.590.700.570"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Méfruside",
"alternateName": "Mefruside",
"url": "https://questionsmedicales.fr/mesh/D008529",
"about": {
"@type": "MedicalCondition",
"name": "Méfruside",
"code": {
"@type": "MedicalCode",
"code": "D008529",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D02.886.590.700.575"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Probénécide",
"alternateName": "Probenecid",
"url": "https://questionsmedicales.fr/mesh/D011339",
"about": {
"@type": "MedicalCondition",
"name": "Probénécide",
"code": {
"@type": "MedicalCode",
"code": "D011339",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D02.886.590.700.625"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Sulfamides",
"alternateName": "Sulfanilamides",
"url": "https://questionsmedicales.fr/mesh/D013424",
"about": {
"@type": "MedicalCondition",
"name": "Sulfamides",
"code": {
"@type": "MedicalCode",
"code": "D013424",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D02.886.590.700.725"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Furosémide",
"alternateName": "Furosemide",
"url": "https://questionsmedicales.fr/mesh/D005665",
"about": {
"@type": "MedicalCondition",
"name": "Furosémide",
"code": {
"@type": "MedicalCode",
"code": "D005665",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D02.886.590.700.725.300"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Sulfacétamide",
"alternateName": "Sulfacetamide",
"url": "https://questionsmedicales.fr/mesh/D013409",
"about": {
"@type": "MedicalCondition",
"name": "Sulfacétamide",
"code": {
"@type": "MedicalCode",
"code": "D013409",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D02.886.590.700.725.650"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Sulfachlorpyridazine",
"alternateName": "Sulfachlorpyridazine",
"url": "https://questionsmedicales.fr/mesh/D013410",
"about": {
"@type": "MedicalCondition",
"name": "Sulfachlorpyridazine",
"code": {
"@type": "MedicalCode",
"code": "D013410",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D02.886.590.700.725.700"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Sulfadiazine",
"alternateName": "Sulfadiazine",
"url": "https://questionsmedicales.fr/mesh/D013411",
"about": {
"@type": "MedicalCondition",
"name": "Sulfadiazine",
"code": {
"@type": "MedicalCode",
"code": "D013411",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D02.886.590.700.725.755"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Sulfadiazine d'argent",
"alternateName": "Silver Sulfadiazine",
"url": "https://questionsmedicales.fr/mesh/D012837",
"about": {
"@type": "MedicalCondition",
"name": "Sulfadiazine d'argent",
"code": {
"@type": "MedicalCode",
"code": "D012837",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D02.886.590.700.725.755.800"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Sulfadiazine d'argent",
"alternateName": "Silver Sulfadiazine",
"url": "https://questionsmedicales.fr/mesh/D012837",
"about": {
"@type": "MedicalCondition",
"name": "Sulfadiazine d'argent",
"code": {
"@type": "MedicalCode",
"code": "D012837",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D02.886.590.700.725.755.800"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Sulfadiméthoxine",
"alternateName": "Sulfadimethoxine",
"url": "https://questionsmedicales.fr/mesh/D013412",
"about": {
"@type": "MedicalCondition",
"name": "Sulfadiméthoxine",
"code": {
"@type": "MedicalCode",
"code": "D013412",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D02.886.590.700.725.760"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Sulfadoxine",
"alternateName": "Sulfadoxine",
"url": "https://questionsmedicales.fr/mesh/D013413",
"about": {
"@type": "MedicalCondition",
"name": "Sulfadoxine",
"code": {
"@type": "MedicalCode",
"code": "D013413",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D02.886.590.700.725.765"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Sulfaguanidine",
"alternateName": "Sulfaguanidine",
"url": "https://questionsmedicales.fr/mesh/D013414",
"about": {
"@type": "MedicalCondition",
"name": "Sulfaguanidine",
"code": {
"@type": "MedicalCode",
"code": "D013414",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D02.886.590.700.725.810"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Sulfalène",
"alternateName": "Sulfalene",
"url": "https://questionsmedicales.fr/mesh/D013415",
"about": {
"@type": "MedicalCondition",
"name": "Sulfalène",
"code": {
"@type": "MedicalCode",
"code": "D013415",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D02.886.590.700.725.850"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Sulfamérazine",
"alternateName": "Sulfamerazine",
"url": "https://questionsmedicales.fr/mesh/D013416",
"about": {
"@type": "MedicalCondition",
"name": "Sulfamérazine",
"code": {
"@type": "MedicalCode",
"code": "D013416",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D02.886.590.700.725.853"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Sulfamétoxydiazine",
"alternateName": "Sulfameter",
"url": "https://questionsmedicales.fr/mesh/D013417",
"about": {
"@type": "MedicalCondition",
"name": "Sulfamétoxydiazine",
"code": {
"@type": "MedicalCode",
"code": "D013417",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D02.886.590.700.725.857"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Sulfadimidine",
"alternateName": "Sulfamethazine",
"url": "https://questionsmedicales.fr/mesh/D013418",
"about": {
"@type": "MedicalCondition",
"name": "Sulfadimidine",
"code": {
"@type": "MedicalCode",
"code": "D013418",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D02.886.590.700.725.862"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Sulfaméthoxazole",
"alternateName": "Sulfamethoxazole",
"url": "https://questionsmedicales.fr/mesh/D013420",
"about": {
"@type": "MedicalCondition",
"name": "Sulfaméthoxazole",
"code": {
"@type": "MedicalCode",
"code": "D013420",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D02.886.590.700.725.867"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Sulfaméthoxypyridazine",
"alternateName": "Sulfamethoxypyridazine",
"url": "https://questionsmedicales.fr/mesh/D013421",
"about": {
"@type": "MedicalCondition",
"name": "Sulfaméthoxypyridazine",
"code": {
"@type": "MedicalCode",
"code": "D013421",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D02.886.590.700.725.872"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Sulfamonométhoxine",
"alternateName": "Sulfamonomethoxine",
"url": "https://questionsmedicales.fr/mesh/D013422",
"about": {
"@type": "MedicalCondition",
"name": "Sulfamonométhoxine",
"code": {
"@type": "MedicalCode",
"code": "D013422",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D02.886.590.700.725.877"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Sulfamoxole",
"alternateName": "Sulfamoxole",
"url": "https://questionsmedicales.fr/mesh/D013423",
"about": {
"@type": "MedicalCondition",
"name": "Sulfamoxole",
"code": {
"@type": "MedicalCode",
"code": "D013423",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D02.886.590.700.725.882"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Sulfanilamide",
"alternateName": "Sulfanilamide",
"url": "https://questionsmedicales.fr/mesh/D000077145",
"about": {
"@type": "MedicalCondition",
"name": "Sulfanilamide",
"code": {
"@type": "MedicalCode",
"code": "D000077145",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D02.886.590.700.725.885"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Sulfapyridine",
"alternateName": "Sulfapyridine",
"url": "https://questionsmedicales.fr/mesh/D013427",
"about": {
"@type": "MedicalCondition",
"name": "Sulfapyridine",
"code": {
"@type": "MedicalCode",
"code": "D013427",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D02.886.590.700.725.900"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Sulfaquinoxaline",
"alternateName": "Sulfaquinoxaline",
"url": "https://questionsmedicales.fr/mesh/D013428",
"about": {
"@type": "MedicalCondition",
"name": "Sulfaquinoxaline",
"code": {
"@type": "MedicalCode",
"code": "D013428",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D02.886.590.700.725.925"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Sulfaméthizol",
"alternateName": "Sulfamethizole",
"url": "https://questionsmedicales.fr/mesh/D013419",
"about": {
"@type": "MedicalCondition",
"name": "Sulfaméthizol",
"code": {
"@type": "MedicalCode",
"code": "D013419",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D02.886.590.700.725.935.813"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Sulfisomidine",
"alternateName": "Sulfisomidine",
"url": "https://questionsmedicales.fr/mesh/D013443",
"about": {
"@type": "MedicalCondition",
"name": "Sulfisomidine",
"code": {
"@type": "MedicalCode",
"code": "D013443",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D02.886.590.700.725.940"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Sulfafurazol",
"alternateName": "Sulfisoxazole",
"url": "https://questionsmedicales.fr/mesh/D013444",
"about": {
"@type": "MedicalCondition",
"name": "Sulfafurazol",
"code": {
"@type": "MedicalCode",
"code": "D013444",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D02.886.590.700.725.945"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Sulfasalazine",
"alternateName": "Sulfasalazine",
"url": "https://questionsmedicales.fr/mesh/D012460",
"about": {
"@type": "MedicalCondition",
"name": "Sulfasalazine",
"code": {
"@type": "MedicalCode",
"code": "D012460",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D02.886.590.700.730"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Tamsulosine",
"alternateName": "Tamsulosin",
"url": "https://questionsmedicales.fr/mesh/D000077409",
"about": {
"@type": "MedicalCondition",
"name": "Tamsulosine",
"code": {
"@type": "MedicalCode",
"code": "D000077409",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D02.886.590.700.863"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Xipamide",
"alternateName": "Xipamide",
"url": "https://questionsmedicales.fr/mesh/D014988",
"about": {
"@type": "MedicalCondition",
"name": "Xipamide",
"code": {
"@type": "MedicalCode",
"code": "D014988",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D02.886.590.700.975"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Sulfonamides",
"alternateName": "Sulfonamides",
"code": {
"@type": "MedicalCode",
"code": "D013449",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Reihane Ghomashi",
"url": "https://questionsmedicales.fr/author/Reihane%20Ghomashi",
"affiliation": {
"@type": "Organization",
"name": "Department of Medicinal Chemistry, Shahreza Branch, Islamic Azad University, P.O. Box 311-86145, Shahreza, Isfahan, Iran."
}
},
{
"@type": "Person",
"name": "Shakila Ghomashi",
"url": "https://questionsmedicales.fr/author/Shakila%20Ghomashi",
"affiliation": {
"@type": "Organization",
"name": "Department of Medicinal Chemistry, Shahreza Branch, Islamic Azad University, P.O. Box 311-86145, Shahreza, Isfahan, Iran."
}
},
{
"@type": "Person",
"name": "Hamidreza Aghaei",
"url": "https://questionsmedicales.fr/author/Hamidreza%20Aghaei",
"affiliation": {
"@type": "Organization",
"name": "Department of Chemistry, Shahreza Branch, Islamic Azad University, P.O. Box 311-86145, Shahreza, Isfahan, Iran."
}
},
{
"@type": "Person",
"name": "Ahmad Reza Massah",
"url": "https://questionsmedicales.fr/author/Ahmad%20Reza%20Massah",
"affiliation": {
"@type": "Organization",
"name": "Department of Chemistry, Shahreza Branch, Islamic Azad University, P.O. Box 311-86145, Shahreza, Isfahan, Iran."
}
},
{
"@type": "Person",
"name": "Satoru Suzuki",
"url": "https://questionsmedicales.fr/author/Satoru%20Suzuki",
"affiliation": {
"@type": "Organization",
"name": "Leading Academia in Marine and Environment Pollution Research (LaMer), Center for Marine Environmental Studies (CMES), Ehime University, Japan."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Roles of long noncoding RNA in triple-negative breast cancer.",
"datePublished": "2023-10-05",
"url": "https://questionsmedicales.fr/article/37795578",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1002/cam4.6600"
}
},
{
"@type": "ScholarlyArticle",
"name": "Long noncoding RNA CLAN promotes lymphangiogenesis in the colorectal carcinoma.",
"datePublished": "2022-10-27",
"url": "https://questionsmedicales.fr/article/36301367",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s00428-022-03439-9"
}
},
{
"@type": "ScholarlyArticle",
"name": "Long noncoding RNA HAND2-AS1: A crucial regulator of malignancy.",
"datePublished": "2022-12-15",
"url": "https://questionsmedicales.fr/article/36528049",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.cca.2022.12.010"
}
},
{
"@type": "ScholarlyArticle",
"name": "Functional roles of long noncoding RNA MALAT1 in gynecologic cancers.",
"datePublished": "2022-08-30",
"url": "https://questionsmedicales.fr/article/36042115",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s12094-022-02914-8"
}
},
{
"@type": "ScholarlyArticle",
"name": "The crucial roles of long noncoding RNA SNHGs in lung cancer.",
"datePublished": "2022-08-25",
"url": "https://questionsmedicales.fr/article/36008615",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s12094-022-02909-5"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Composés chimiques organiques",
"item": "https://questionsmedicales.fr/mesh/D009930"
},
{
"@type": "ListItem",
"position": 3,
"name": "Composés du soufre",
"item": "https://questionsmedicales.fr/mesh/D013457"
},
{
"@type": "ListItem",
"position": 4,
"name": "Sulfones",
"item": "https://questionsmedicales.fr/mesh/D013450"
},
{
"@type": "ListItem",
"position": 5,
"name": "Sulfonamides",
"item": "https://questionsmedicales.fr/mesh/D013449"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Sulfonamides - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Sulfonamides",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-13",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Sulfonamides",
"description": "Comment diagnostiquer une infection nécessitant des sulfonamides ?\nQuels tests sont utilisés pour évaluer l'efficacité des sulfonamides ?\nLes sulfonamides sont-ils efficaces contre toutes les bactéries ?\nQuels signes cliniques indiquent une infection bactérienne ?\nComment confirmer une infection urinaire ?",
"url": "https://questionsmedicales.fr/mesh/D013449?mesh_terms=RNA,+Long+Noncoding&page=2#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Sulfonamides",
"description": "Quels sont les symptômes d'une infection traitée par sulfonamides ?\nLes sulfonamides provoquent-ils des effets secondaires ?\nComment reconnaître une réaction allergique aux sulfonamides ?\nQuels symptômes indiquent une surinfection ?\nLes sulfonamides peuvent-ils causer des troubles gastro-intestinaux ?",
"url": "https://questionsmedicales.fr/mesh/D013449?mesh_terms=RNA,+Long+Noncoding&page=2#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Sulfonamides",
"description": "Comment prévenir les infections nécessitant des sulfonamides ?\nLes sulfonamides peuvent-ils être utilisés en prophylaxie ?\nQuelles mesures d'hygiène sont recommandées ?\nLes vaccinations aident-elles à prévenir les infections ?\nComment éviter la résistance aux antibiotiques ?",
"url": "https://questionsmedicales.fr/mesh/D013449?mesh_terms=RNA,+Long+Noncoding&page=2#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Sulfonamides",
"description": "Comment les sulfonamides sont-ils administrés ?\nQuelle est la posologie habituelle des sulfonamides ?\nLes sulfonamides peuvent-ils être combinés avec d'autres antibiotiques ?\nQuel suivi est nécessaire lors d'un traitement par sulfonamides ?\nLes sulfonamides sont-ils efficaces contre les infections virales ?",
"url": "https://questionsmedicales.fr/mesh/D013449?mesh_terms=RNA,+Long+Noncoding&page=2#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Sulfonamides",
"description": "Quelles complications peuvent survenir avec les sulfonamides ?\nComment gérer une réaction allergique sévère aux sulfonamides ?\nLes sulfonamides peuvent-ils causer des troubles rénaux ?\nQuels signes indiquent une complication grave ?\nLes sulfonamides peuvent-ils interagir avec d'autres médicaments ?",
"url": "https://questionsmedicales.fr/mesh/D013449?mesh_terms=RNA,+Long+Noncoding&page=2#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Sulfonamides",
"description": "Qui est à risque de développer des effets secondaires aux sulfonamides ?\nLes personnes âgées sont-elles plus à risque avec les sulfonamides ?\nLes femmes enceintes peuvent-elles prendre des sulfonamides ?\nLes patients atteints de maladies hépatiques sont-ils à risque ?\nLes antécédents d'infections récurrentes augmentent-ils le risque ?",
"url": "https://questionsmedicales.fr/mesh/D013449?mesh_terms=RNA,+Long+Noncoding&page=2#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une infection nécessitant des sulfonamides ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un diagnostic repose sur des symptômes cliniques et des cultures bactériennes."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour évaluer l'efficacité des sulfonamides ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests de sensibilité aux antibiotiques sont réalisés sur des échantillons microbiologiques."
}
},
{
"@type": "Question",
"name": "Les sulfonamides sont-ils efficaces contre toutes les bactéries ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, leur efficacité varie selon le type de bactérie et leur résistance."
}
},
{
"@type": "Question",
"name": "Quels signes cliniques indiquent une infection bactérienne ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Fièvre, douleur, rougeur et gonflement peuvent indiquer une infection."
}
},
{
"@type": "Question",
"name": "Comment confirmer une infection urinaire ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un examen d'urine et une culture permettent de confirmer une infection urinaire."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes d'une infection traitée par sulfonamides ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Fièvre, douleur, fatigue et symptômes locaux selon l'infection."
}
},
{
"@type": "Question",
"name": "Les sulfonamides provoquent-ils des effets secondaires ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des effets comme éruptions cutanées, nausées ou réactions allergiques peuvent survenir."
}
},
{
"@type": "Question",
"name": "Comment reconnaître une réaction allergique aux sulfonamides ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Éruptions cutanées, démangeaisons, ou gonflement peuvent indiquer une allergie."
}
},
{
"@type": "Question",
"name": "Quels symptômes indiquent une surinfection ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Augmentation de la douleur, fièvre persistante et écoulement purulent peuvent indiquer une surinfection."
}
},
{
"@type": "Question",
"name": "Les sulfonamides peuvent-ils causer des troubles gastro-intestinaux ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des nausées, vomissements ou diarrhées peuvent survenir avec leur utilisation."
}
},
{
"@type": "Question",
"name": "Comment prévenir les infections nécessitant des sulfonamides ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Maintenir une bonne hygiène, se faire vacciner et éviter les contacts avec des malades."
}
},
{
"@type": "Question",
"name": "Les sulfonamides peuvent-ils être utilisés en prophylaxie ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ils peuvent être prescrits en prophylaxie pour prévenir certaines infections."
}
},
{
"@type": "Question",
"name": "Quelles mesures d'hygiène sont recommandées ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Se laver les mains régulièrement et éviter le partage d'objets personnels."
}
},
{
"@type": "Question",
"name": "Les vaccinations aident-elles à prévenir les infections ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines vaccinations peuvent réduire le risque d'infections bactériennes."
}
},
{
"@type": "Question",
"name": "Comment éviter la résistance aux antibiotiques ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Utiliser les antibiotiques uniquement lorsque prescrit et suivre les recommandations médicales."
}
},
{
"@type": "Question",
"name": "Comment les sulfonamides sont-ils administrés ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils sont généralement administrés par voie orale ou intraveineuse selon l'infection."
}
},
{
"@type": "Question",
"name": "Quelle est la posologie habituelle des sulfonamides ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "La posologie varie selon l'infection, mais doit être prescrite par un médecin."
}
},
{
"@type": "Question",
"name": "Les sulfonamides peuvent-ils être combinés avec d'autres antibiotiques ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ils peuvent être utilisés en association pour élargir le spectre d'action."
}
},
{
"@type": "Question",
"name": "Quel suivi est nécessaire lors d'un traitement par sulfonamides ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un suivi régulier pour surveiller les effets secondaires et l'efficacité est recommandé."
}
},
{
"@type": "Question",
"name": "Les sulfonamides sont-ils efficaces contre les infections virales ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, les sulfonamides ne sont pas efficaces contre les infections virales."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec les sulfonamides ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des réactions allergiques graves, des troubles sanguins ou des lésions hépatiques peuvent survenir."
}
},
{
"@type": "Question",
"name": "Comment gérer une réaction allergique sévère aux sulfonamides ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Cesser immédiatement le traitement et consulter un médecin pour un traitement approprié."
}
},
{
"@type": "Question",
"name": "Les sulfonamides peuvent-ils causer des troubles rénaux ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des troubles rénaux peuvent survenir, nécessitant une surveillance de la fonction rénale."
}
},
{
"@type": "Question",
"name": "Quels signes indiquent une complication grave ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Fièvre élevée, éruption cutanée étendue ou difficulté respiratoire peuvent indiquer une complication."
}
},
{
"@type": "Question",
"name": "Les sulfonamides peuvent-ils interagir avec d'autres médicaments ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ils peuvent interagir avec d'autres médicaments, augmentant le risque d'effets secondaires."
}
},
{
"@type": "Question",
"name": "Qui est à risque de développer des effets secondaires aux sulfonamides ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les personnes ayant des antécédents d'allergies médicamenteuses sont à risque accru."
}
},
{
"@type": "Question",
"name": "Les personnes âgées sont-elles plus à risque avec les sulfonamides ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les personnes âgées peuvent avoir un risque accru d'effets secondaires et de complications."
}
},
{
"@type": "Question",
"name": "Les femmes enceintes peuvent-elles prendre des sulfonamides ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'utilisation doit être évitée, car elle peut affecter le fœtus. Consultez un médecin."
}
},
{
"@type": "Question",
"name": "Les patients atteints de maladies hépatiques sont-ils à risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ils peuvent avoir un risque accru d'effets indésirables et nécessitent une surveillance."
}
},
{
"@type": "Question",
"name": "Les antécédents d'infections récurrentes augmentent-ils le risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les antécédents d'infections récurrentes peuvent nécessiter un traitement plus agressif."
}
}
]
}
]
}
Long noncoding RNAs (lncRNAs) play crucial roles in regulating various hallmarks in cancers. Triple-negative (Estrogen receptor, ER; Human epidermal growth factor receptor 2, HER2; Progesterone recept...
We reviewed the current literature on the roles of lncRNAs in the pathogenesis, therapy resistance, and prognosis of patients with TBNC....
LncRNAs are associated with TNBC pathogenesis, therapy resistance, and prognosis. For example, lncRNAs such as small nucleolar RNA host gene 12 (SNHG12), highly upregulated in liver cancer (HULC) HOX ...
In this review, we outline the functions of various lncRNAs along with their molecular mechanisms involved in the pathogenesis, therapeutic resistance of TBNC. Also, the prognostic implications of lnc...
Metastasis is the main cause of colorectal cancer (CRC)-related death and lymph node plays a vital role in this process. Long noncoding RNAs (lncRNAs) are emerging as an important factor of biological...
Long non-coding RNAs (LncRNAs) are single-stranded RNAs over 200 nucleotides in length that have no protein-coding function and have long been considered non-functional by-products of transcription. R...
Gynecologic cancers are reproductive disorders characterized by pelvic pain and infertility. The identification of new predictive markers and therapeutic targets for the treatment of gynecologic cance...
Lung cancer is one of the most common malignant tumors with growing morbidity and mortality worldwide. Several treatments are used to manage lung cancer, including surgery, radiotherapy and chemothera...
The main pathological change of myocarditis is an inflammatory injury of cardiomyocytes. Long noncoding RNAs (lncRNAs) are closely related to inflammation, and our previous study showed that different...
RNA expression was measured by quantitative reverse-transcription polymerase chain reaction (RT-qPCR). Lipopolysaccharide (LPS) was used to induce inflammation in human cardiomyocytes (HCMs). The expr...
NONHSAT122636.2 was dynamically expressed in patients with myocarditis and negatively correlated with inflammation severity. The overexpression of NONHSAT122636.2 improved inflammatory injury in LPS-s...
NONHSAT122636.2 attenuates myocardial inflammation and apoptosis in myocarditis. Additionally, its expression decreases in the peripheral blood of children suffering from myocarditis and in patients w...
IgA nephropathy (IgAN) is one of the most common primary glomerular diseases worldwide, especially in young Asian adults. Long RNA H19 is associated with renal pathologies, such as renal cell injury; ...
Our cohort consisted of 204 patients with IgAN. Serum H19 levels were determined with reverse-transcription quantitative polymerase between 1 May, 2014 and 1 May, 2015. H19 levels were log-transformed...
H19 expression was significantly downregulated in patients with IgAN compared to healthy controls. Restricted cubic spline analyses showed that the relationship was negatively and linearly correlated ...
H19 is an independent protective factor, and a high level of H19 often indicates better renal outcome within 5 years....
Increasing evidence has demonstrated that high TTN-AS1 expression is highly related to poor prognosis in diverse human cancers. However, the findings concerning the prognostic value of TTN-AS1 were in...
Web of Science, Springer, Embase, PubMed, Cochrane Library, and Scopus databases were comprehensively searched to retrieve studies related to the TTN-AS1 expression with the prognosis of malignancies....
Twenty studies involving 17 different cancers and 1330 patients were recruited into this meta-analysis. The research revealed that high TTN-AS1 expression was remarkably associated with unfavorable ov...
The results of this meta-analysis support that high TTN-AS1 expression significantly correlates with worse prognosis in various cancers. Therefore, TTN-AS1 may be considered as a novel biomarker for m...
Macrophages play an essential role in maintaining the normal function of the innate and adaptive immune responses during host defence. Macrophages acquire diverse functional phenotypes in response to ...
Cancer has become the most common life-threatening disease in the world. Cancers presenting with advanced stages and metastasis show poor prognosis, even with the application of radiotherapy, surgery,...